HealthCCSng vs Study Watch with Irregular Pulse Monitor (Home)
AI Verdict
Choose HealthCCSng if…
Choose HealthCCSng if your primary goal is to opportunistically assess a patient's risk of coronary artery disease by leveraging existing or routinely performed chest CT scans. This AI-powered solution is ideal for automatically detecting and quantifying coronary artery calcification, streamlining risk stratification within a radiology or cardiology workflow without requiring additional dedicated cardiac imaging.
View HealthCCSng →Choose Study Watch with Irregular Pulse Monitor (Home) if…
Choose the Verily Study Watch with Irregular Pulse Monitor (Home) if you need to continuously monitor patients for cardiac arrhythmias, such as atrial fibrillation, in a remote or home setting. This prescription-only wearable is best suited for clinical research or for patients requiring long-term, unobtrusive physiological data collection and irregular pulse monitoring beyond episodic clinic visits.
View Study Watch with Irregular Pulse Monitor (Home) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HealthCCSng | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| Pricing | Not publicly available | Unknown |
| Deployment | Cloud-based, integrates with PACS and EMR systems | Unknown |
| FDA Status | Yes AI-estimated | Unknown |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
HealthCCSngHealthCCSng offers a highly automated workflow that seamlessly integrates with existing PACS and EMR systems, requiring minimal human intervention from clinicians. In contrast, the Verily Study Watch, while designed for unobtrusive data collection, is a wearable device that necessitates patient compliance for continuous wear and potential interaction for on-demand measurements.
Clinical Value
TieBoth tools offer significant clinical value in their respective domains. HealthCCSng provides critical, actionable insights into coronary artery disease risk by automatically quantifying CAC from routine CT scans, enabling early intervention for a prevalent condition. The Verily Study Watch, an FDA-cleared wearable, offers continuous physiological data collection and irregular pulse monitoring for AFib detection, which is vital for managing chronic cardiac conditions and advancing clinical research.
Pricing & Value
HealthCCSngHealthCCSng has established a reimbursement pathway with a new Category III CPTu00ae code, which provides a clear mechanism for healthcare providers to realize financial value from its use. In contrast, the Verily Study Watch's pricing is not publicly available, and while it is used for clinical research, there is no explicit mention of established reimbursement codes for its direct clinical application, making its financial value proposition less transparent for healthcare systems.
Enterprise Readiness
HealthCCSngHealthCCSng demonstrates strong enterprise readiness through its seamless integration with existing PACS and EMR systems, FDA clearance, and clear HIPAA compliance. The Verily Study Watch, despite its FDA clearance, faces significant challenges to enterprise adoption due to a reported lawsuit alleging HIPAA breaches and unauthorized data use, which could impact trust and compliance for healthcare organizations.
Innovation
Study Watch with Irregular Pulse Monitor (Home)The Verily Study Watch demonstrates greater innovation by offering a multi-modal wearable device that unobtrusively collects continuous physiological and environmental data for clinical research and monitoring in real-world settings. While HealthCCSng innovates by applying AI to existing CT scans for opportunistic CAC detection, the Study Watch's comprehensive sensor suite and focus on continuous, diverse data collection for digital biomarkers represents a broader advancement in health data acquisition and analysis.
Support & Docs
Study Watch with Irregular Pulse Monitor (Home)Verily provides a user manual for the Study Watch and offers comprehensive clinical trial support, including regulatory, development, operations, and compliance assistance for its platform. In contrast, specific details regarding support and documentation for HealthCCSng were not readily available in the provided information or search results.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HealthCCSng | Study Watch with Irregular Pulse Monitor (Home) |
|---|---|---|
| Name | HealthCCSng | Study Watch with Irregular Pulse Monitor (Home) |
| Company | Nano-X AI | Verily Life Sciences LLC |
| Primary Function | Analyzes routine CT scans to automatically detect and quantify coronary artery calcification (CAC), identifying patients at risk of coronary artery disease. | Unobtrusively collect physiological data, including ECG and irregular pulse monitoring, with advanced sensors and cloud-based analytics. |
| Analyzed Data/Input | Non-contrast, non-ECG gated chest CT scans | On-demand single-channel ECG measurement, irregular pulse, heart rate, electrodermal activity, inertial movements, environmental sensors. |
| Detected Condition(s) | Coronary Artery Disease (via CAC detection) | Irregular pulse for atrial fibrillation (AFib) detection |
| Categories | Cardiology AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology, Radiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring HealthCCSng and Study Watch with Irregular Pulse Monitor (Home).